Company page
Lytix Biopharma Asa
Lytix Biopharma Asa, trading under the ticker 6BG, is a public company listed in Germany with a market capitalization of approximately €72.67 million. The company focuses on developing innovative cancer therapies. Lytix Biopharma aims to advance its pipeline of treatments to improve patient outcomes in oncology.
- Ticker
- LYTIX:OSL
- Asset type
- Stock
- Market cap
- $72.7M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- OSL
- Currency
- NOK